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Genomic analysis of transcriptional
networks directing progression of cell
states during MGE development
Magnus Sandberg1* , Leila Taher2, Jianxin Hu3,6, Brian L. Black3, Alex S. Nord4,5 and John L. R. Rubenstein1*
Abstract
Background: Homeodomain (HD) transcription factor (TF) NKX2–1 critical for the regional specification of the
medial ganglionic eminence (MGE) as well as promoting the GABAergic and cholinergic neuron fates via the
induction of TFs such as LHX6 and LHX8. NKX2–1 defines MGE regional identity in large part through transcriptional
repression, while specification and maturation of GABAergic and cholinergic fates is mediated in part by
transcriptional activation via TFs such as LHX6 and LHX8. Here we analyze the signaling and TF pathways,
downstream of NKX2–1, required for GABAergic and cholinergic neuron fate maturation.
Methods: Differential ChIP-seq analysis was used to identify regulatory elements (REs) where chromatin state was
sensitive to change in the Nkx2–1cKO MGE at embryonic day (E) 13.5. TF motifs in the REs were identified using
RSAT. CRISPR-mediated genome editing was used to generate enhancer knockouts. Differential gene expression in
these knockouts was analyzed through RT-qPCR and in situ hybridization. Functional analysis of motifs within hs623
was analyzed via site directed mutagenesis and reporter assays in primary MGE cultures.
Results: We identified 4782 activating REs (aREs) and 6391 repressing REs (rREs) in the Nkx2–1 conditional knockout
(Nkx2–1cKO) MGE. aREs are associated with basic-Helix-Loop-Helix (bHLH) TFs. Deletion of hs623, an intragenic Tcf12
aRE, caused a reduction of Tcf12 expression in the sub-ventricular zone (SVZ) and mantle zone (MZ) of the MGE.
Mutation of LHX, SOX and octamers, within hs623, caused a reduction of hs623 activity in MGE primary cultures.
Conclusions: Tcf12 expression in the SVZ of the MGE is mediated through aRE hs623. The activity of hs623 is
dependent on LHX6, SOX and octamers. Thus, maintaining the expression of Tcf12 in the SVZ involves on TF
pathways parallel and genetically downstream of NKX2–1.
Keywords: TCF12, SOX, OCT, LHX, MEIS, Medial ganglionic eminence, CRISPR engineering, Transcriptional network,
Neurogenesis
Background
Transcription factors (TFs) direct cell fate determination
and differentiation through binding to a genomic net-
work consisting of regulatory elements (REs) such as
promoters and enhancers. By analyzing epigenetic modi-
fications and transcriptional changes in TF knockouts,
we have started to uncover the genomic networks and
molecular mechanisms that direct brain development
[1]. In-depth understanding of the genetically encoded
wiring of the brain is important as perturbation of tran-
scription pathways is implicated in disorders such as
autism and intellectual disability [2]. Distantly acting
REs have been identified based on conservation and
activity [3, 4]. Their spatial activity and dynamic gen-
omic contacts can be predicted using a combination of
TF binding profiling, genome-wide 3D chromosome
organization mapping and CRISPR/Cas9 editing [5–10].
Mouse genetic experiments have elucidated the func-
tions of many TFs in the development of the subpallial
telencephalon [11, 12]. These studies show that the HD
protein NKX2–1 is required for regional specification of
the MGE by repressing alternative identities, as well as
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promoting GABAergic and cholinergic cell fates via the
induction of TFs such as LHX6 and LHX8 [13–17]. By
integrating genomic data with mouse genetics, we con-
firmed the repressive function of NKX2–1, however its
role in transcriptional activation remains unclear. More-
over, additional data suggests that genes genetically
downstream of NKX2–1, such as LHX6 and LHX8, are
responsible for the loss of gene expression observed in
the Nkx2–1cKO [18, 19]. Altogether, the genetic pro-
gram and molecular mechanisms responsible for pro-
moting GABAergic and cholinergic neuron phenotypes,
downstream of NKX2–1 remains largely unexplored.
To investigate the signaling pathways of MGE devel-
opment downstream of NKX2–1, we extended our earl-
ier analysis of the genomic network directing MGE
development that is altered in the Nkx2–1 mutant. First
we evaluated all loci that showed an epigenetic change,
independent of NKX2–1 binding. Via an epigenomic
analysis of the NKX2–1 mutant MGE we characterized
a large set REs that are implicated in mediating tran-
scriptional repression and activation. Using a combin-
ation of genomics, de novo motif analysis, CRISPR
engineering and primary culture assays we characterize
REs and TFs central to patterning of the subpallial telen-
cephalon and promoting MGE characteristics. Gene
ontology (GO) analysis showed an enriched association
of REs activating transcription (aREs) with E-box bind-
ing basic-Helix-Loop-Helix (bHLH) TFs. Using CRISPR
engineering we deleted hs623, an intronic aRE of the
Tcf12 gene which encodes a bHLH TF. Deletion of
hs623 reduced Tcf12 expression in the MGE. De novo
motif analysis combined with TF motif mutations,
showed that OCT/POU and SOX motifs are required
for hs623’s ability to promote transcription in the MGE.
Methods
Mice
The Nkx2–1cKO was earlier described in Sandberg et al.
2016 [18] and generated using mice strains previously
reported: Nkx2–1f/f [20], Olig2-tva-Cre [21] and AI14
Cre-reporter [22]. All experiments with animals com-
plied with federal and institutional guidelines and were
reviewed and approved by the UCSF Institutional Ani-
mal Care and Use Committee.
Generation of hs623 deletion
The hs623Tm1 allele was generated by CRISPR-mediated
genome editing, using established methods [23]. Guide
RNAs sgRNA-hs623–1, 5′-GTTTAGTTTTGCTCATAC
CA(TGG)-3′ and sgRNA-hs623–2, 5′-ATGGTTTCT
GTGATCGTAAT(TGG)-3′ (protospacer-adjacent motif
[PAM] sequence indicated in parentheses) were tran-
scribed in vitro using the MEGAshortscript T7 kit (Life
Technologies, AM1354) and subsequently purified using
the MEGAclear kit (Life Technologies, AM1908). The
two guide RNAs were designed to delete a 737 bp in-
tronic region within Tcf12 [mm9; chr9:71822812–
71823548]. The purified sgRNAs were co-injected into
the cytoplasm of fertilized mouse oocytes with in vitro
transcribed Cas9 mRNA using standard transgenic proce-
dures as previously described [24]. F0 transgenic founders
were identified by PCR screening using hs623-KO-F, 5′-
GTCATTGTTGCTGTTGGCCT -3′ and hs623-KO-R,
5′- CCACCTCACACTAGATTAAGATACA -3′ to iden-
tify the hs623 null alleles (KO = 250 bp, WT= 1008 bp)
and hs623-WT-F, 5’-GTGGCTGATGATGTGCTCTGA
-3′ and hs623-WT-R, 5’-CTCCATCAGGTTCTTGCCC
C-3′ to identify the hs623-WT allele (462 bp). Four inde-
pendent F0 founders were each outcrossed to wild type
mice, and F1 offspring were used for subsequent hs623Tm1
intercrosses to generate hs623-null mice. The hs623 mu-
tant strain (CD1-Tcf12em1Jlr/Mmucd) is available at
MMRC (www.mmrrc.org/) with the number RRID: MMR
RC_044027-UCD.
Histology
Immunofluorescence was performed on 16 μm cryosec-
tion as previously described [25]. In situ hybridization
was performed as previously described [26]. The follow-
ing primers were used generate the templates used for
the in situ probes: Tcf12_F, TCTCGAATGGAAGA
CCGC; Tcf12_R, CTCCCTCCTGCCAGGTTT.
Dissection of embryos
RT-qPCR and primary culture experiments were per-
formed on E13.5 micro-dissected MGE. All MGE dissec-
tions were performed as follows; the dorsal boundary
was defined by the sulcus separating lateral ganglionic
eminence (LGE) and MGE. The caudal end of the sulcus
defined the caudal boundary. Septum was removed.
Gene expression analysis in hs623KO
To assay differential gene expression in the hs623KO
RNA was purified using RNEasy Mini (Qiagen) and
cDNA was generated using Superscript III® First-Strand
Synthesis System for RT-PCR (Invitrogen). RT-qPCR
analysis was performed on a 7900HT Fast Real-Time
PCR System (Applied Biosystems) using SYBR GreenER
qPCR SuperMix (Invitrogen, Cat. No. 11760–100). Un-
paired t-test was used to test significance in gene expres-
sion between hs623WT and hs623KO using SDHA as
internal control [27, 28].
Sequences of RT-qPCR primers used:
SDHA-F, GCTCCTGCCTCTGTGGTTGA
SDHA-R, AGCAACACCGATGAGCCTG
Mns1_ctrl_1F, CTGCTGCTCCGGAAGACG
Mns1_ctrl_1R, TTTTGGTCGCCATCTCGGTT
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Myzap_ctrl_2F, TCGAAAGGAAAGATCAGCCTCC
Myzap_ctrl_2R, TCTGATCTTCGCACCACACC
Zfp280d_ctrl_1F, CCCCAGCTCTCATTCAAGAGG
Zfp280d_ctrl_1R, TTCAGGCAGCGTTGACTTGT
TCF12_v1/2-F2, GCTTGTCCCCAACACCTTTC
TCF12_v1/2-R2, TGACAGCCTGAGAGTCCAGA
TCF12_v1/3-F4, TACCAGTCAGTGGCCCAGAG
TCF12_v1/3-R4, AATGCTCGTGAAGTTGCTGC
TCF12_v1/3-F5, TCCCTGGAATGGGCAACAAT
TCF12_v1/3-R5, TCACGGTTGAAATCGTCAGA
Site-directed mutagenesis of TF binding motifs in hs623
To study the requirement TF motifs for hs623 activity
LHX6, SOX and octamers were mutated in pCR-Blunt
II-TOPO, sequence verified and sub-cloned into a
pGL4.23-Luciferase reporter with a minimal β-globin
-promoter using BglII and XhoI [18]. Following primers
were used to generate the different hs623 luciferase
reporters:
hs623-mut-site#1-R, cgttgctgacaaggctgttttttacagaaattg
atgctgagttc
hs623-mut-site#1-F, agccttgtcagcaacgtgattattcaaac
hs623-mut-site#2-F, gatgtgctctgatatgaaaaaagtcattaggt
agaatgaatag
hs623-mut-site#3-F, gatgtgctctgatatgtaattagaaaaaaggtag
aatgaatag
hs623-mut-site#2 and 3-F, gatgtgctctgatatgaaaaaagaaaa
aaggtagaatgaatag
hs623-mut-site#2 and/or 3-R, atatcagagcacatcatcagcca
cattc
hs623-mut-site#4-F, gattattcaaacaactcttttttttgttaatgagg
hs623-mut-site#4-R, gagttgtttgaataatcacgttgctgac
hs623-mut-site#5-F, ctcatgcaaatgaaaaagaggccttatttgc
hs623-mut-site#5-R, atttgcatgagttgtttgaataatc
hs623-mut-site#4 and 5-F, caaacaactcttttttttgaaaaaga
ggccttatttgc
hs623-mut-site#4 and 5-R, use “hs623-mut-site#4-R”
for PCR
hs623-mut-site#6-F, gttaatgaggccttaaaaaaatatttattttttcc
hs623-mut-site#6-R, ggcctcattaacatttgcatgagttgtttg
hs623-mut-site#4 and 6-F, caactcttttttttgttaatgaggcctta
aaaaaatatttattttttcc
hs623-mut-site#4 and 6-R, cattaacaaaaaaaagagttgtttgaa
taatcac
hs623-mut-site#4,5 and 6-F, caactcttttttttgaaaaagaggcc
ttaaaaaaatatttattttttcc
hs623-mut-site#4, 5 and 6-R, ggcctctttttcaaaaaaaaga
gttgtttgaataatc
hs623-mut-site#7-F, gcaacgtgattattcccccccctcatgcaaatg
hs623-mut-site#7-R, gaataatcacgttgctgacaagg
hs623-mut-site#4 and 7-F, gtgattattcccccccctctttttttt
gttaatgagg
hs623-mut-site#4 and 7-R, use hs623-mut-site#7-R
Analysis of hs623 activity in MGE primary MGE cultures
MGE tissue was dissected from E13.5 embryos, tritu-
rated and plated onto 24-well plates (1 embryo/2wells).
Primary cultures were transfected with a total of 500 ng
DNA using Lipofectamin 2000 (Thermo Fisher) and cul-
tured in Neurobasal Medium (Thermo Fisher) supple-
mented with 0.5% Glucose, GlutaMAX (Thermo Fisher
Scientific) and B27 (Thermo Fisher Scientific). Luciferase
assays were performed 48 h after transfection using Dual
Luciferase Reporter Assay System (Promega). Unpaired
t-test was used to test significance between the variants
of hs623.
ChIP-Seq computational analysis
Differential ChIP-seq analysis was performed as de-
scribed in Sandberg et al. 2016 [18]. After differential
H3K4me1, H3K27ac and H3K27me3 analysis we merged
overlapping sites. Only merged sites that were enriched
in H3K4me1 relative to the input datasets and for which
the difference in enrichment between Nkx2–1 WT and
cKO was not significant (for at least one of the sites
among the merged sites) were further considered. Of those,
merged sites overlapping with blacklisted genomic regions
(http://mitra.stanford.edu/kundaje/akundaje/release/black-
lists/mm9-mouse/mm9-blacklist.bed.gz) and RepeatMasker
annotation (http://hgdownload.cse.ucsc.edu/goldenPath/
mm9/database/chr*_rmsk.txt.gz) as well as those exceeding
5000 bp were excluded. We defined aREs based on the
following two criteria; 1) more H3K27ac (WT) and no
increase in H3K27me3 (WT), H3K27ac (Nkx2–1cKO) and
H3K4me1 (Nkx2–1cKO), 2) more H3K27me3 (Nkx2–
1cKO) and no increase in H3K27ac (Nkx2–1cKO),
H3K4me1 (Nkx2–1cKO) and H3K27me3 (WT). We de-
fined rREs based on the following two criteria; 1) more
H3K27ac (Nkx2–1cKO) and no increase in H3K27me3
(Nkx2–1cKO), H3K27ac (WT) and H3K4me1 (WT), 2)
more H3K27me3 (WT) and no increase in H3K27ac (WT),
H3K4me1 (WT) and H3K27me3 (Nkx2–1cKO).
In vivo analysis of aREs and rREs
To assess the in vivo activity of aREs and rREs we used
the data published in the VISTA Enhancer Browser
(https://enhancer.lbl.gov/) [7]. All aREs and rREs, over-
lapping with regions tested in the VISTA Enhancer
Browser were scored based on their in vivo activity in
cortex, MGE and LGE. For the MGE active elements,
we also scored their activity in the ventricular zone
(VZ), SVZ and MZ.
De novo motif analysis
Motif analysis was performed using RSAT [29], identify-
ing overrepresentation and positional bias of words (6 to
7 nucleotides) in the aREs and rREs using an automated
Markov model adapted after the analyzed sequence
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length. Differential analysis of aREs (rREs as control se-
quence) and rREs (aREs as control sequence) was also
performed to identify overrepresented words in the peak
sequence.
Results
Identification of the genomic regulatory network
directing MGE identity
We have previously shown that the combined binding of
NKX2–1 and LHX6 is a predictive indicator of REs that
mediate transcriptional activation in the subventricular
(SVZ) and mantle zone (MZ) of the MGE in the devel-
oping subpallial telencephalon [18]. There is evidence
that NKX2–1 generally acts as a repressor in MGE pro-
genitors (in the ventricular zone [VZ]), whereas LHX6,
and potentially other TFs and signaling pathways, some
of which are genetically downstream of NKX2–1, are
important for activating transcription in the SVZ and
MZ of the MGE [18, 30]. By studying aREs, we aimed to
further explore the molecular mechanisms underlying
the transcriptional network directing differentiation of
the secondary progenitors in the SVZ. One important
difference between this study and our earlier study [18]
is that here we look at all aREs and rREs, independent of
NKX2–1 binding.
First we identified aREs and rREs by assessing the
genome-wide changes of the two histone marks
H3K27ac and H3K27me3 at H3K4me1 positive REs
comparing the WT and Nkx2–1cKO MGE [18]. We de-
fined aREs based on the following two criteria; 1) re-
duced H3K27ac and, 2) increased H3K27me3 in the
Nkx2–1cKO. We defined rREs based on the following
two criteria; 1) increased H3K27ac and, 2) reduced
H3K27me3 in the Nkx2–1cKO (see Methods).
Based on these criteria we identified 4782 aREs and
6391 rREs in the Nkx2–1cKO. See Additional file 1 for a
complete list of aREs and rREs. To analyze the in vivo
activity patterns of the aREs and rREs we examined
transgenic enhancer activity patterns of E11.5 forebrain
enhancer activity patterns available in the VISTA data-
base (see VISTA data base; https://enhancer.lbl.gov/) [7].
The activities of rREs were highest in cortex (62% [13 of
21]) and LGE and dorsal MGE (52% [11 of 21]) and low-
est in the ventral MGE (24% [5 of 21])(Fig. 1a and b
[hs848, hs1172 and hs1187]). In contrast, aREs have the
highest activities in the MGE (53% [17 of 32]) when
compared to their activities in the LGE (50% [16 of 32])
and cortex (41% [13 of 32]) (Fig. 1a and b [hs676, hs957
and hs1041]). We also found a higher activity of MGE
positive aREs in the SVZ (71% [12 of 17]) and MZ (94%
[16 of 17]) compared to the VZ (18% [3 of 17]), consist-
ent with our previous results for NKX2–1 bound aREs
and rREs (Fig. 1b and c) [18]. See Additional file 1 for a
full list of aREs and rREs VISTA transgenics.
To identify TFs motifs enriched in the aRE and rREs
we performed a de novo motif discovery using RSAT
[29]. This analysis showed a number of motifs enriched
in both aREs and rREs such as SOX motifs, homedo-
main binding motifs (HOX and POU6f2) and motifs
recognized by zinc finger TFs (e.g. SP1 and ZNF384)
(Fig. 1d and e). Additional analysis identifying motifs dif-
ferentially enriched between aREs and rREs showed that
aREs have a high frequency of E-boxes (Fig. 1e). Interest-
ingly, we found that rREs are enriched in motifs consist-
ent with the binding site of the TF MEIS2 (Fig. 1d). The
Meis2 gene is repressed by NKX2–1, and in turn, its
RNA is strongly up-regulated in the MGE of the Nkx2–
1cKO [18]. These data suggest that Meis2 is central to
activating a genomic network promoting LGE and cau-
dal ganglionic eminence (CGE) characters (through
rREs) in the Nkx2–1cKO MGE.
We then examined enrichment of annotation terms
among the aREs and rREs candidate target genes using
GREAT [31]. Top-ranked GO terms for rREs target
genes were associated with WNT signaling (beta-catenin
binding and PDZ domain binding), transcriptional regu-
lation (such as RNA polymerase II transcription
co-activator activity), and enhancer sequence-specific
DNA binding (Fig. 1f ). Looking specifically at the associ-
ated genes for the rREs containing MEIS2 binding motifs
we found several genes (Isl1, Ebf1, Tle4, Zfp503, Efnb1
and Efnb2) with higher expression in the LGE and CGE
than the MGE. These findings support the hypothesis
that MEIS2 directs LGE and CGE identities. The
top-ranked GO terms for aREs target genes were associ-
ated with phosphatase activity, E-box binding proteins,
L-glutamate transmembrane transporter activity and
transmembrane-ephrin receptor activity [31] (Fig. 1f ).
Two E-box binding TFs, Tcf4 and Tcf12, which are in the
region of a large number of aREs, have reduced MGE
SVZ and MZ expression in the Nkx2–1cKO [18]. In
combination with the high frequency of E-boxes in aREs,
our data suggests that Tcf4 and Tcf12 are components of
the genomic network regulating gene expression in sec-
ondary progenitors of the MGE that are genetically
downstream of NKX2–1.
In vivo characterization of hs623 in the MGE of the
forebrain
To learn more about the Tcf12 expression and the tran-
scriptional pathways integrated in the aRE network
downstream of NKX2–1, we examined aRE hs623, a
highly evolutionarily conserved 914 base pair (bp) se-
quence that is in an intron of the Tcf12 locus (Fig. 2a
and b). A previous transgenic study show that hs623
drives LacZ expression at E11.5 [32]. The hs623 trans-
gene is active in the forebrain, hindbrain and the spinal
cord (Fig. 2c-e, Additional file 2). A coronal section
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through the telencephalon shows that hs623 activity is
restricted to the SVZ and MZ of the MGE, and perhaps
labels cell tangentially migrating into the LGE (Fig. 2e).
This pattern of activity is supported by histone ChIP-seq
analysis of the MGE showing that this locus has histone
modifications that are characteristic of active enhancer
elements (Fig. 2a [H3K4me1+ and H3K27ac+] and 2B).
Of note, ChIP-seq analysis of the MGE Nkx2–1cKO
shows reduced H3K27ac, providing evidence that the
activity of the locus is dependent on the activity of
the NKX2–1 and/or its target TFs, as reported earlier
(Fig. 2b) [18].
Motif logic direct region specific transcriptional activity
Hs623 is flanked by two highly conserved regions and
the activity of one of the regions (hs357) has been tested
in vivo [32]. Similar to hs623, hs357 is active in the
spinal cord, but unlike hs623 it is active in the pretectum
and it lacks activity in the telencephalon, including the
MGE (Fig. 2f and g). Therefore, despite the close prox-
imity of hs623 and hs357, they show differences in re-
gional activity, suggesting that their regional activities
are more likely due to differences in their primary nu-
cleic acid sequence rather then their genomic location.
Consistent with the lack of MGE activity, hs357 has two
NKX2–1 consensus motifs and no LHX6 consensus mo-
tifs (Fig. 2b). On the other hand, hs623 has four LHX6
consensus motifs, which could explain its activity in the
MGE (Fig. 2h). Even though hs623 has NKX2–1 binding,
it contains no NKX2–1 consensus motifs. However, the
sequences flanking hs623 do include three NKX2–1 con-
sensus motifs, two within hs357 (Fig. 2b). In agreement
with these observations, we detect NKX2–1 binding cov-
ering a wide region that incudes both hs623 and hs357.
Fig. 1 Characterization of aREs and rREs in E13.5 MGE. a Proportion of aREs and rREs active in MGE, LGE and cortex. b Sections of transgenic
embryos (from the VISTA browser) showing in vivo activity of rREs (hs848, hs1172 and hs1187) and aREs (hs676, hs957 and hs1041) at E11.5. c VZ,
SVZ, and MZ activity of aREs in the MGE at E11.5. Chi-square test was used to test significance between the groups: *p < 0.05. d and e Manually
curated list of de novo motifs and potential TF recognizing the motifs in rREs and aREs. f Enriched gene ontology annotations of putative aRE
target genes
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CRISPR/Cas9 mediated deletion of hs623 in vivo
To functionally test the requirement of hs623 in vivo, we
deleted hs623 using CRISPR/Cas9 (see VISTA database;
http://enhancer.lbl.gov). A pair of sgRNAs was designed
to delete the 734 bp core sequence of hs623, which has
NKX2–1 and LHX6 binding (Fig. 2b and h).
Fig. 2 Deletion of cis-regulatory element hs623 in vivo. a Genomic region of the Tcf12 locus with the ChIP-seq datasets and genomic features
shown; NKX2–1 ChIP-seq, LHX6 ChIP-seq, H3K4me3, H3K4me1, H3K27ac, H3K27me3, UCSC genes and mammalian conservation. Histone 3
modifications in MGE at E13.5. Hs623 region framed and highlighted in blue. b Higher resolution view of the hs623 region with the same ChIP-
seq datasets as in Fig. 2a. Called NKX2–1 & LHX6 binding region, VISTA regions, deleted hs623 region (yellow) and NKX2–1, LHX6 and OCT
consensus motifs labeled at the top of the browser. c-g VISTA database transgenic embryos showing in vivo activity of hs623 and hs357 at E11.5.
h Schematic description of the generated hs623 deletions (5 founders). The distribution of LHX6 consensus motifs in hs623 are indicated. Founder
2458 was used for the analysis presented in this paper
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Microinjection of sgRNAs and Cas9 generated a total of
22 pups. 23% (5 of 22) of the pups carried the desired
hs623 deletions and the induced DNA breaks were dis-
tributed within 20 bp of the predicted cutting site (5′
and 3′ of hs623, Fig. 2h, Additional file 3). To minimize
potential off target effects we outcrossed the F0 transgenic
founders to wild-type CD1 mice. Four of five founders
were fertile and generated a F1 generation; these animals
were intercrossed to generate homozygous F2 hs623KO
animals. Hs623KOs in the F2 generation were produced at
Mendelian Ratios showing that the enhancer deletion was
viable (10[WT]:19[HET]:7[KO], n = 3 litters; χ2 = 0.611; df
= 2; p = 0.7367). Due to the overall similarity of the four
fertile founders we decided to focus the following analysis
on one of the founders (F0: 2458, Fig. 2h).
Deletion of hs623 reduces Tcf12 mRNA levels in the SVZ
of MGE
Hs623 is a Tcf12 intragenic RE that in transgenic assays
activates transcription in the SVZ of the MGE (Fig. 2c-e).
As noted above, its activity is partly dependent on NKX2–
1 activity and Tcf12 transcription is specifically reduced in
the SVZ of the MGE in the Nkx2–1cKO (Fig. 2b) [18].
Together, these data suggest that hs623 could be a RE
activating Tcf12 transcription in the MGE. To test this
hypothesis, we performed RTqPCR on the MGE from
hs623WTs and hs623KOs at E13.5. Primers were designed
to target all known mouse protein-coding and non-pro-
tein-coding genes in the NCBI RNA reference se-
quences collection that are found 450 kb up- and
downstream of hs623 (Fig. 3a). From the RTqPCR we
found no significant difference in the expression of
the following genes in this region: Myzap, Cgln1,
Zfp280d and Mns1 (Fig. 3b). Tcf12 RNAs include a
variety of splice variants. Because of this we designed
three separate primer pairs to specifically interrogate
the different splice variants of Tcf12 (Fig. 3a). We
found a reduction in the expression of the short iso-
forms of Tcf12 isoform 3 and 4 (Fig. 3b, see
Tcf12_v1/3–4 and Tcf12_v1/3–5). Notably, we did not
find any difference in the expression levels of the lon-
ger isoforms 1 and 2 of Tcf12 (Fig. 3b, see Tcf12_v1/
2–2). Together, these results show that Tcf12 tran-
scription in the MGE is enhanced by hs623.
Fig. 3 Reduced Tcf12 expression in the hs623KO. a Tcf12 locus with neighboring genes. b qPCR analysis of Mns1, Myzap, Cgln1, Zfp280d, Tcf12
isoforms 1 and 3 (Tcf12_v1/3–4), Tcf12 isoforms 3 and 4 (Tcf12_v1/3–5), Tcf12 variant 1 and 2 (Tcf12_v1/2–2) on WT and hs623KO MGE at E13.5.
The colors used in the table correlate to the specific target regions indicated in Fig. 3a. c and d In situ hybridization analysis of Tcf12 in WT (c)
and hs623KO (d) basal ganglia at E13.5. Unpaired t-test was used to test significance between the groups: *p < 0.05
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To obtain spatial information about the reduction of
Tcf12 within the MGE we compared the distribution of
Tcf12 RNA between WT and hs623KO telencephalon at
E13.5 using in situ RNA hybridization. Normally, Tcf12
is broadly expressed in the VZ in the pallium and sub-
pallium. In the ganglionic eminences Tcf12 is also
expressed in the SVZ and MZ, with a markedly higher
expression in the MGE compared to the LGE. On the
other hand, in the hs623KO we observed a reduction of
Tcf12 expression that appeared to be specific to the SVZ
and MZ of the MGE (Fig. 3c and d). This result is con-
sistent with the spatial activity of hs623, which is re-
stricted to the SVZ of the MGE.
Combined activity of POU and SOX TFs are required to
maintain gene expression downstream of NKX2–1 in the
MGE
To test the functional requirement of the LHX6 motifs
in hs623 we made site directed mutations that removed
all four LHX6 motifs (hs623ΔLHX). In MGE primary
cultures the activity of hs623ΔLHX was reduced by half
when compared to the non-mutated hs623 (hs623WT,
Fig. 4a and b). Together, these experiments provide evi-
dence that hs623 activity, in part, depends on LHX6 and
LHX8 and that there are additional TFs and signaling
pathways required for the activity of hs623. Our earlier
motif analysis of aREs discovered an enrichment of add-
itional motifs such as HD-binding motifs (POU6f2 and
HOX), SOX motifs and E-boxes (Fig. 1e). To identify
additional TF pathways responsible for the activity of
hs623 we looked at the other identified de novo motifs
within hs623 (Fig. 1d). Located in the center of hs623 we
found two octamers (bound by POU TFs), of which one
is adjacent to a SOX motif. Octamers are known to pair
with SOX motifs to form central functional units regulating
development in various cell types [33–35]. Initially, we
analyzed the activity of the two individual octamers by
generating single mutations of the two motifs (Fig. 4a,
hs623ΔOCT1 and hs623ΔOCT2). Mutating octamer 1
(hs623ΔOCT1) caused a significant reduction of hs623 ac-
tivity in MGE primary cultures, whereas mutating octamer
2 (hs623ΔOCT2) had no significant effect on hs623 activity
(Fig. 4b). Octamer 2 is located 3 bp from a SOX consensus
motif (Fig. 4a). To assess the requirement of this combined
motif for hs623 activity, we generated a compound mutant
with a combined mutation of octamer 2 and the paired
SOX motif (hs623ΔOCT2 + SOX). Hs623ΔOCT2 + SOX
showed a significantly reduced activity when compared to
hs623WT as well as, the two individual single mutants,
hs623ΔOCT2 and hs623ΔSOX (Fig. 4b).
Fig. 4 OCT and SOX motifs required for hs623 activity in primary MGE cultures. a Schematic of hs623 with LHX6, OCT and SOX motifs. b
Luciferase reporter assay showing a reduced activity of hs623 when LHX6, OCT and SOX motifs in hs623 are mutated. Data are represented as
mean ± SEM. Unpaired t-test was used to test significance between the groups: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
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Altogether, our experiments show that Tcf12 expres-
sion in the SVZ of the MGE is mediated, at least in part,
through hs623, a RE that is strongly dependent on its
OCT and SOX motifs and partially dependent on its
LHX6 motifs. We have previously shown that gene ex-
pression in the SVZ of the MGE (including Tcf12) largely
depends on NKX2–1 activity [18]. Existing mechanistic
data show that NKX2–1 acts as a transcriptional repres-
sor. Therefore, our findings suggest that the loss of
Tcf12 expression in the SVZ of the MGE Nkx2–1cKO is
not due to the direct regulation of Tcf12 by NKX2–1,
but is a secondary effect due to changes in expression
and activity of LHX6, LHX8, OCT and SOX TFs.
Discussion
Technical advancements in genome wide sequencing,
chromosome capture and CRISPR/Cas9 technologies are
increasing our understanding of genome organization.
These data, combined with data showing RE activities in
vivo (https://enhancer.lbl.gov/), TF binding and other
epigenetic genomic data, and spatial gene expression
data (http://www.brain-map.org/, http://www.eurexpres-
s.org/ee/intro.html), are enabling the field to begin eluci-
dating the genomic networks and the molecular
mechanisms that direct brain development. Herein we
have used many of these approaches to analyze gene ex-
pression in the developing mouse MGE. In the context
of the Nkx2–1cKO mouse, our analysis of differential
(WT vs. cKO) histone ChIP-seq data, and de novo se-
quence motif analysis, has provided evidence for add-
itional TFs, REs, and signaling pathways that direct
MGE development.
In this study, we showed that Tcf12 expression in the
SVZ of the MGE is mediated via hs623, an aRE bound
by NKX2–1. The activity of hs623 and the expression of
Tcf12 depend on NKX2–1 activity, suggesting that
NKX2–1 promotes Tcf12 expression in this context. We
find no direct evidence showing that NKX2–1 activates
Tcf12 transcription via hs623. On the other hand, we
show that LHX6, OCT and SOX motives are central to
hs623 activity. In fact, hs623 lacks NKX2–1 consensus
motifs and its interaction with hs623 can possibly be ex-
plained through binding to three flanking regions. Other
alternative explanations are that NKX2–1 regulates
hs623 through either uncharacterized NKX2–1 motifs or
through indirect binding to transcriptional complexes
that bind hs623.
We have earlier demonstrated that NKX2–1 represses
transcription in the MGE, similar to other NKX HD TFs
that specify ventral parts of the developing neural tube
[36, 37]. Even at aREs, identified in the Nkx2–1cKO
MGE, the NKX2–1 motifs mediate transcriptional re-
pression, as exemplified by the intragenic Tgfb3 RE in
Sandberg et al. 2016 [18]. On the other hand, in the case
of both the Tgfb3 RE and hs623, LHX6 motifs promote
enhancer activity. If NKX2–1 only represses transcrip-
tion, it is unclear how loci such as LHX6 and LHX8 fail
to be activated in the Nkx2–1 mutants [16–18]. Further-
more it is unclear why NKX2–1 also binds loci that have
reduced activity in the Nkx2–1cKO. These results sug-
gest that, in some contexts, NKX2–1 may have an acti-
vating function. NKX2–1 binding to these loci might be
required to keep them poised for subsequent activation
by TFs and signaling pathways parallel and genetically
downstream of NKX2–1, such as LHX, OCT, SOX and
bHLH TFs. A similar model was presented in two stud-
ies looking at motor neuron development. In these cells,
combinations of NEUROG2 (bHLH TF), LHX3, ISL-1,
ONECUT1 and EBF direct the progression of the motor
neuron fate through distinct sets of REs [8, 9]. Similar to
these models, we find an enrichment of LHX6 binding
and e-boxes at aREs, a group of REs with a preferential
activity in the SVZ of the MGE. This combination of TF
binding and motif enrichment is not seen at NKX2–1
bound rREs, that have a relatively low MGE activity.
These data highlight similarities in the molecular mecha-
nisms that direct MGE and motor neuron development
over time. In addition to combinatorial activity with
other TFs, the activity of NKX2–1 might be affected by
changes to chromatin modifications at specific loci over
time. Our experimental design lacks the temporal reso-
lution to make these kinds of predictions. For the future,
it would be interesting to know; 1) at what time point in
the developing MGE (VZ, SVZ or MZ) are the various
REs active, 2) and the temporal pattern of TF binding at
these REs. This would give us important information
that could help elucidate the activating and repressing
mechanics through which NKX2–1, LHX6 and other
TFs direct MGE development.
The seemingly dual activity of NKX2–1 in the MGE is
similar to its double-edged characteristics in regulating
cancer development and progression. In this context,
NKX2–1 has a role as lineage-survival oncogene in de-
veloping lung cancer tumors. On the other hand,
NKX2–1 expression is also associated with a favorable
prognosis in affected patients, due to its capacity to at-
tenuate the invasive capacity of carcinomas [38]. Inter-
estingly, this has been shown to be mediated through an
abrogation of cellular response to TGFβ induced EMT, a
signaling pathway that is directly repressed by NKX2–1
in the MGE [18, 39]. By identifying the mechanisms
through which NKX2–1 operate in the subpallial telen-
cephalon we might also learn more about its enigmatic
role in tumor biology.
The activity of the RE hs623 depends on two octamers,
providing evidence that OCT TFs are central to MGE
development. OCT TFs are important regulators of stem
cell maintenance and the progression of neurogenesis.
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OCT4 is central for propagating undifferentiated embry-
onic stem cells and has the ability to induce pluripotent
stem cells from embryonic and adult fibroblasts [40, 41].
On the contrary, BRN2, together with Ascl1 and Myt1l,
can efficiently trans-differentiate embryonic and postna-
tal fibroblasts into functional neurons [42]. BRN1, BRN2
and OCT6 mutants show defects in layering of the neo-
cortex, due to their role in initiating radial migration of
cortical projection neurons, further highlighting their
role in promoting neurogenesis [43–45]. Furthermore,
we find an enrichment of both octamers and E-boxes in REs
promoting gene expression in the MGE, suggesting that the
TF machinery directing trans-differentiation of fibroblasts
into neurons is similar to the TF machinery inducing neur-
onal phenotypes in the MGE. Trans-differentiating fibro-
blast to neurons using Brn2, Ascl1 and Myt1l generate cells
with a mixed neuronal phenotype [42], indicating that these
TFs are required for promoting the neuronal fate, without
any preference for specific neuronal lineages. Taken to-
gether, this suggests a model where neuronal fate and
phenotype is directed through separate, although integrated,
TF pathways in the MGE.
One of the octamers in hs623 is paired with a SOX
motif. The SOX TF family consists of a large number of
genes that direct embryonic development and cell differ-
entiation. They bind loosely to the minor groove of the
DNA and their target gene specificity is guided through
the interaction with cell type specific partner factors
such as OCT TFs. The combined activity of SOX2 and
different OCT TFs are important regulators of gene ex-
pression in undifferentiated embryonic stem cells (ESCs)
and neural progenitor cells (NPCs) [46]. SOX2 and
OCT4 (POU5F1) bind REs in ECSs, whereas SOX2 and
BRN2 (POU3F2) co-occupy REs in NPCs [34, 46–48].
SOX and OCT motifs have also been shown to direct
transcription in both ESCs and NPCs in the forebrain
[34, 35]. Today we do not know what specific OCT and
SOX TFs that are required to activate transcription in
the SVZ of the MGE, via REs like hs623, BRN1
(POU3F3), BRN2 (POU3F2), BRN4 (POU3F4), BRN5
(POU6F1) and OCT6 (POU3F1) are all expressed here,
but little is know regarding their function in this context.
A large number of different SOX TFs are expressed in
the MGE and several of them show a reduced expression
in the Nkx2–1cKO, such as Sox1, Sox2, Sox6, Sox11 and
Sox21 constituting possible candidates for promoting
Tcf12 expression via hs623. Sox6 is required for pattern-
ing of the subpallium and generation on MGE derived
interneurons [49, 50], but when looking at Tcf12 expres-
sion in the E13.5 MGE of a conditional Sox6 mouse [51]
with an Nkx2–1-Cre line [52], we found no significant
change in Tcf12 expression (Additional file 4). From this
we can suggest that SOX6 is not sufficient for promoting
Tcf12 expression. Further studies should be performed
to identify the specific OCT and SOX TFs directing
transcriptional activation in the MGE.
Here, in our new analysis of the Nkx2–1cKO, we
found a large number aREs. Some of these are near the
loci of the Tcf4 and Tcf12 bHLH TF encoding genes. The
Nkx2–1cKO shows a near complete loss of Tcf12 expres-
sion in the SVZ and MZ of the MGE. We found an aRE
intronic to Tcf12 (hs623) that has activity in the SVZ
and MZ of the MGE (Fig. 2e). Deletion of hs623 leads to
a reduced Tcf12 expression in the VZ and MZ of the
MGE. This result suggests that Tcf12 expression is regu-
lated through several aREs, including hs623, and that
there is redundancy between these REs. Enhancer redun-
dancy has been demonstrated in the developing telen-
cephalon and limb where REs sharing a similar
spatiotemporal activity provides robustness to gene ex-
pression [53, 54]. We also find that there are different
genetic programs directing Tcf12 expression in various
cell types of the MGE. Tcf12 expression is initiated in
the VZ of the MGE; this expression is largely unaffected
in the Nkx2–1cKO, indicating that Tcf12 expression in
this region is not mediated through hs623 and largely
NKX2–1 independent.
Altogether, these data provide evidence of transcrip-
tional circuitry that connects the initiation of MGE fate
in the VZ by Nkx2–1 and Otx2, to the maturation of
cells in the SVZ and MZ by driven through REs such
as hs632, whose activity integrates signals from LHX,
OCT, SOX and bHLH TFs [16, 18, 55]. Future stud-
ies will investigate how TFs, chromatin-binding,
−reading and -remodeling proteins integrate to direct
GABAergic and cholinergic development in the sub-
pallial telencephalon.
Conclusion
In our study we use a combination of genomics,
CRISPR/Cas9 engineering and TF motif analysis to in-
vestigate the transcriptional networks guiding develop-
ment of the MGE and its descendants. Whereas NKX2–
1 is required for initiating MGE characteristics in the
VZ, we provide evidence that a combination of LHX,
OCT, SOX and bHLH TFs are central for maintaining
gene expression in the SVZ and MZ, genetically
down-stream of NKX2–1. Here we generate a mouse
mutant in whom we delete a Tcf12 intragenic RE, show-
ing its requirement for maintaining Tcf12 transcription
in the SVZ and MZ of the MGE. The activity of this
Tcf12 enhancer, in primary cultures of MGE cells, largely
depends on an octamer and a combined octamer and
SOX motif. Altogether, our study identifies a genomic
framework through which a combination of LHX, OCT,
SOX and bHLH TFs direct MGE differentiation through
the expression terminal effector genes.
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